Swiss nonprofit BIO Association to launch BIO tokens for decentralized biotech network

Share This Post

The BIO Association, a Swiss nonprofit, has unveiled plans to launch BIO tokens ahead of its decentralized biotech network, BIO Protocol, according to a Sept. 30 statement shared with CryptoSlate.

The association seeks to bridge the gap between biotechnology and crypto through its decentralized biotech network. This platform will serve as a launchpad for on-chain science communities.

In addition, it aims to democratize access to scientific research and funding. Central to this goal is creating BioDAOs—community-led organizations that develop and finance scientific intellectual property.

The BIO Association spun out from Molecule AG, a Swiss company specializing in tokenization infrastructure for DeSci organizations.

Currently, the BIO Network hosts eight scientific communities focused on longevity, women’s health, neurodegeneration, and synthetic biology. So, the initiative can potentially transform the biotech industry by leveraging blockchain technology and DeSci principles.

Notably, the platform has raised more than $5 million through an auction in August.

BIO token

The BIO Association has committed to a fair and transparent token launch designed to mirror major token releases. This approach highlights the community’s dedication to equal opportunity in the growing DeSci space.

Once the tokens are launched, users will be able to acquire BIO tokens using ETH or other DAO tokens within the BIO network.

The genesis phase will last 45 days or until the BIO token reaches a fully diluted valuation (FDV) of $100 million. After this period, the tokens will be non-transferable until a governance vote decides otherwise.

The token’s mainnet launch will occur on Ethereum, aligning with other leading DeSci projects.

BIO token holders will be able to vote on which new BioDAOs join the network. Additionally, they will gain whitelisted access to science-focused funding from top universities and researchers.

Meanwhile, early BIO Genesis token holders include ZeePrime Capital, Beaker DAO, Boost VC, 1kx, ID Theory, Compound, Cherry Crypto, L1D, Fifty Years, Northpond Ventures, KdT Ventures, Sora Ventures, and The LAO.

The post Swiss nonprofit BIO Association to launch BIO tokens for decentralized biotech network appeared first on CryptoSlate.

Read Entire Article
spot_img
- Advertisement -spot_img

Related Posts

61 New Bitcoin Addresses Holding 1,000 to 10,000 BTC Emerge in 2024

Recent data reveals that bitcoin wallets holding between 01 and 1 BTC have grown by an impressive 9,563 since the year began Meanwhile, the number of crab wallets containing 1 to 10 BTC has shrunk by

EigenLayer Founder Reiterates Support For Ethereum, Why Is ETH Struggling?

Despite scalability and high gas fees facing Ethereum, the founder of EigenLayer, a liquidity restaking platform, insists the network is superior, especially against Solana Solana is the third most

Ohio senator introduces bill to legalize Bitcoin, crypto payments for state taxes, fees

Ohio State Senator Niraj Antani introduced legislation aiming to legalize Bitcoin (BTC) and other crypto payments for taxes and fees in the state of Ohio and its local political subdivisions The bill

Australian lender ANZ partners with Chainlink to explore RWA tokenization

Australia’s second-largest bank, ANZ, has partnered with Chainlink Labs and ADDX to explore tokenized real-world assets, according to a Sept 30 statement shared with CryptoSlate The move is

Bittensor’s TAO Flips ICP to Become Second Largest AI Coin Amid Market Shift

According to the latest market trends, the artificial intelligence (AI) coin bittensor (TAO) has overtaken internet computer (ICP), now sitting as the second largest AI-focused coin, just below near

Crypto Guru Warns: Only 6 Years Left To ‘Make As Much Money As Possible’

Raoul Pal, the founder of Real Vision and a recognized figure in the crypto community, has issued a stark warning about the rapidly approaching transformations in the global economy, driven by